ODAC Unanimously Recommends Promacta for ITP, FDA Approves New Indication for Implantable Beacon Electromagnetic Transponders


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles